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Abstract
Background: There is a positive association between raised resting heart rate (RHR), and all causes of mortality and
shorter life expectancy. Several serum biomarkers and some anthropometric factors can affect the resting heart rate.
This study aimed to investigate the determinants of resting heart rate in a large random sample of the Iranian
population.
Material and methods: It is a standardized, retrospective study and the subjects were chosen from the baseline
survey of the Prospective Epidemiological Research Study in IrAN (PERSIAN) Fasa non-communicable disease cohort
study. It was conducted from winter 2014 to summer 2019 and after obtaining informed consent from a random
sample, all the eligible subjects were enrolled. All anthropometric factors and biologic laboratory factors were
collected and analyzed by implement smoothly clipped absolute deviation (SCAD) linear regression and SCAD
quantile regression. The comparisons between males and females were done via independent T-test.
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Results & conclusion: A total number of 9975 persons from 35 to 90 years old were included. The overall median
resting heart rate was 74 (interquartile range:66–80). Mean age has no important difference between males and
females (P = 0.79) but, resting heart rate was significantly higher in females (76.6 versus 71.4, P < 0.001). All
anthropometric factors except wrist circumference were higher in females (P < 0.05). Age has an adverse effect on
resting heart rate and also, there was a direct association between resting heart rate and systolic blood pressure
and blood glucose. Alpha-blockers (coefficient = 5.2) and Beta1-blockers (coefficient = − 2.2) were the most effective
drugs with positive and negative effects on resting heart rate respectively. Lower hemoglobin, obesity, and more
body mass index, and more low-density lipoprotein were associated with more resting heart rate.
Continuing the monitoring of this sample via our cohort study and put to action multinational prospective
researches with large sample sizes and long follow-ups can lead to more precise results and better scientific
judgments.
Keywords: Resting heart rate, BMI, Alpha-blockers
Introduction
Elevated resting heart rate (RHR) is associated with an
increased risk of cardiovascular disease and shorter life
expectancy [1]. Epidemiologic studies have demonstrated
that elevated RHR is strongly associated with all causes
of mortality, atherosclerosis, and arterial stiffness [2, 3].
Metabolic abnormalities, left ventricular dysfunction,
and ventricular Arrhythmias showed to be correlated
with higher resting heart rate in general population and
some subgroups including the hypertensive and those
with established coronary artery disease (CAD) [4]. A
few studies have shown that some biologic laboratory
factors can affect the resting heart rate, particularly in
non-Western populations [5–7]. For example, some of
the previous investigators have explored the relationship
between higher RHR and the increased blood pressure,
and demonstrated that there is a positive correlation [8,
9]. However, there are significant controversies in the re-
sults of previous surveys [10–12]. And to the best of our
knowledge, all of these studies have been performed in
western population and also didn’t adjust all major bio-
markers of cardiovascular health. Since there are limited
population-based studies that investigate factors affect-
ing resting heart rate variations, the question arises:
“which biochemical factors determine the level and vari-
ation of heart rate at the community level?”
Anthropometric factors are known as a reliable way to
the measurement of the size and proportion of the hu-
man body. Body Mass Index (BMI), waist circumference
(WC), waist to hip ratio (WHR), waist to height ratio
(WHtR) forming classic obesity indices and A body
shape index (ABSI), abdominal volume index (AVI),
body adiposity index (BAI) and conicity index, formed
modern obesity indices. Evidences are suggesting that
abdominal obesity is related to high sympathetic nerve
activity which probably mediated by elevated leptin and
insulin levels [13, 14]. Also, it seems that in people with
larger body mass, the blood circulation takes longer, so
affects the heart rate to prevent diastolic pressure drop
[15]. Recent evidence from the data of 4360 participants
in French RECORD Study, showed that RHR was
strongly related to BMI and body fat distribution but
without a definite pattern [6]. Waist circumference has
previously been shown to be associated with RHR but
the exact mechanism is indistinct [16].
Unfortunately, previous studies have analyzed the as-
sociation between classic anthropometric factors and
RHR in adolescents, and lots of other aspects and a spe-
cific pattern are still less clear [6, 12]. Therefore, the aim
of this extensive, standardized, retrospective cohort
study is to review the determinants of resting heart rate
in a large random sample of the Iranian population.
Method
Study population
The data used in this paper were driven from the base-
line survey of the PERSIAN (Prospective Epidemiological
Research Study in IrAN) cohort Study (Fasa non-
communicable disease cohort study) [17]. It was con-
ducted from Nov. 2014 to June 2019 and was the first
large epidemiological study, surveying a random sample
from the general population in southern Iran. The pur-
pose, design, and method of the study have been pub-
lished in detail elsewhere [17, 18]. A total number of
9975 persons from 35 to 90 years old were included. The
mean and median age of the participants were 49.63 ±
9.17 and 48 years, respectively. In men, the mean age
was 49.58 ± 9.49 and the median age was 47 years. The
youngest man was 35 years old and the oldest was 85
years old. In women, the mean age was 49.64 ± 9.58 and
the median age was 48 years. The youngest woman
was 35 years old and the oldest was 90 years old. The
study was approved by the research ethics committee
of Fasa University of medical sciences (No. IR.FUMS.-
REC.1396.228) and after obtaining informed consent,
all the eligible subjects were enrolled.
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Measures
Resting heart rate
According to the recommendations of the International
Standards for Anthropometric Assessment (ISAK),
trained nurses measured RHR by electrocardiogram
(Cardionics CardioPlug device) to minimize coefficients
of variation [19]. The measurement was made in a quiet
room after a 5 min rest period in the supine position
from 9 to 11 a.m. Each measurement was made three
times and the average value was calculated.
Anthropometric factors
Bodyweight was measured to the nearest 0.1 kg using an
electronic scale (Seca 769 scale, Seca GMBH, Hamburg).
Height was measured to the nearest 0.5 cm using a stadi-
ometer (Seca 769 scale, Seca GMBH, Hamburg). BMI
(Kg/m2) was calculated as weight (Kg) divided by
squared height (m2) (thin: BMI < 18, average: 18 ≤ BMI <
25, overweight: 25 ≤ BMI < 30, obese: BMI ≥ 30). Waist
and hip circumferences were measured using flexible
plastic tape. Waist circumference (WC) was measured at
the midpoint between the inferior border of the lowest
ribs and the superior iliac crest. The measurement was
done at the end of a normal expiration while the individ-
ual stood upright, with feet next together and arms
hanging freely at the sides. Hip circumference was mea-
sured over no restrictive underwear at the level of the
maximum extension of the buttocks in a horizontal
plane, without compressing the skin. (HP < 94, 94 ≤HP ≤
102 and HP > 102 among men and HP < 80, 80 ≤HP ≤
88 and HP > 88 among women).
All anthropometric calculations were done according
to the following equations:
A body shape index ABSIð Þ ¼ WC
BMI
2

3  Height1

2
Abdominal volume index AVIð Þ
¼ 2 WCð Þ2 þ 0:7 waist−hipð Þ2 =1000
Body adiposity index BAIð Þ ¼ Hip
Height1:5
−18
conicity ¼ WC mð Þ
0:109
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Weight Kgð Þ
Height mð Þ
s
The percentage of body fat was obtained by the Tetra-
polar Bioelectrical Impedance Analysis (BIA) system
(BF-350, Tanita Corp, Tokyo, Japan). Subjects stood on
the metal contacts with bare feet and their body fat mass
was determined. This measurement was repeated twice,
and the average value was calculated and set.
Drugs
The drugs that have been considered for use and whose
role in the relationship has been modified are as follows:
Tricyclic antidepressant (Imipramine, Amitriptyline,
Doxepin, Nortriptyline); Beta-blockers (Propranolol,
Atenolol, Carvedilol, Metoprolol); Alfa blockers (Prazo-
sin, Terazosin); Selective serotonin reuptake inhibitor
(Fleuxetin, Sertraline, Citalopram, Escitalopram, Paroxe-
tine); Antihistamines (Hydroxyzine, Ketotifen, Lorata-
dine, Desloratadine, Ciproheptadin, Fexofenadine);
Calcium channel blockers (Amlodipine, Nefidipine, Dil-
tiazem, Verapamil); Diuretics (Furosemide, Spfinolac-
tone, Triamtren H, Hydrochlorothiazide, Triamterene);
Beta 2 agonist (Clonidine).
Statistical methods
To consider the large number of variables in the current
study, we implement smoothly clipped absolute devi-
ation (SCAD) linear regression which is one the best in
terms of variable selection in regression modeling.
SCAD estimates the coefficient of unimportant variables
as zero and removes them from the model, therefore it
does simultaneous estimation and variable selection.
Also, to assess the association between variables across
the distribution of resting heart rate, we used SCAD
quantile regression instead of traditional quantile regres-
sion for the same reason. In this study, RHR as a
dependent variable and SBP, HDL. C, WBC, GLUC,
Beta1-blockers, TG, SGPT, DBP, Age, SGOT, BUN,
WC, Opium, TCA; Alpha-Blockers, HGB, Levothyrox-
ine, Metformin, SSRI, Diuretics, LDL, Beta2-agonist,
Antihistamine, ABSI, and sex entered the model as pre-
dictive variables. All the factors were compared between
males and females via independent T-test in SPSS 22.0
software and figures were drawn in Prism 5.0 software.
Moreover, ncvreg and rqpen packages in R 3.3.2 software
were used for regression modeling.
Results
Our sample comprised of 9975 persons including 5468
(54.8%) females and 4507 (45.2%) males. The median
resting heart rate was 74 (interquartile range:66–80) and
10th and 90th were 61 and 88 respectively. Although
there was no significant difference between mean age of
females (49.6) and males (49.5), resting heart rate was
significantly higher in females (76.6 versus 71.4, P <
0.001). Comparing anthropometric factors between
males and females showed that all the factors except
wrist circumference were higher in females (P < 0.05).
Furthermore, Table 1 shows a comparison between
males and females in terms of some biological and an-
thropometric factors.
The frequency of use of different drug groups in the
study population is shown in Fig. 1.
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Age has an adverse effect on resting heart rate and the
female gender was directly associated with a faster rest-
ing heart rate. Also, there was a direct association be-
tween resting heart rate and SBP and blood glucose.
Also, the positive association between diastolic blood
pressure and resting heart rate was observed only for
below 80th quantile (Fig. 2). Figure 2 shows the relation-
ship of different quantiles of resting heart rate with the
proven important variables, and aims to find the
strength of this relationship in different quantiles to
show whether the relationship of this variable to resting
heart rate is generally established, or only in certain
amounts of heart rate.
In order to investigate the simultaneous effect of dif-
ferent factors on resting heart rate, we proposed two
models based on SCAD linear regression. In model 1,
HR considered as a dependent variable, and all of the
other 41 factors (aforementioned in Table 1 and drugs)
were considered as independent variables. The proposed
model represents 25 variables as effective factors on rest-
ing heart rate and remove the other variables from the
model by estimating their coefficients equal to zero.
These variables were ordered in Table 2 based on their
importance.
The second model (model 2) only comprised age, sex,
BMI, waist circumference, WHR, SBP, and drugs be-
cause the excluded variables show a bidirectional con-
founding relationship with RHR (this is probably due to
the same correlations that exist with other independent
variables). As shown in Table 2, the female gender is the
most effective factor on resting heart rate, with the mean
RHR for females is 4.62 bpm higher compared to males.
Meanwhile, increasing each 20 years of age leads to one
decrease in resting heart rate. Considering Pharmaceut-
ical categories, Alpha-blockers (coefficient = 5.2) and
Beta1-blockers (coefficient = − 2.2) were the most effect-
ive drugs.
Discussion
The mean resting heart rate in our population was 74
bpm that is more in comparison with noted reports. In
light of the evidence, previous studies report resting
heart rate must be ranges 60 to 65 in a healthy popula-
tion [20, 21]. This superiority leads to an increasing
prevalence of the cardiovascular disease in our society
[22, 23]. Also, this discrepancy may be due to some
underlying diseases in the selected population.
A significant negative correlation of aging with heart
rate have been described by Ogliari et al. in 2015 [24]. In
this context, several studies have suggested that age
could be related to RHR [9, 25, 26]. We demonstrated
that there is a strong negative association between aging
and RHR which is independent of other cardiovascular
risk factors in both sex. Of course, the difference
Table 1 Anthropometric and biological factors in males and
females in Fasa PERSIAN (Prospective Epidemiological Research
Study in IrAN) cohort study
Variable Male (n = 4507) Female (n = 5468) P-value
Mean SD Mean SD
Heart Rate (bpm) 71.40 10.13 76.59 10.46 < 0.001
Age (years) 49.52 9.69 49.57 9.59 0.79
Waist circumference (cm) 89.52 11.18 96.14 11.49 < 0.001
Hip circumference (cm) 97.54 7.67 101.25 9.41 < 0.001
Wrist circumference (cm) 17.28 1.23 16.27 1.25 < 0.001
DBP (mm Hg) 74.88 11.39 75.36 11.79 0.04
SBP (mm Hg) 111.39 17.20 112.76 18.87 < 0.001
BMI 24.20 4.41 26.86 4.81 < 0.001
ABSI 0.08 0.00 0.09 0.01 < 0.001
BAI 26.47 3.70 34.15 5.11 < 0.001
AVI 16.35 4.12 18.79 4.47 < 0.001
Conicity index 1.29 0.08 1.37 0.08 < 0.001
WHR 0.92 0.06 0.95 0.06 < 0.001
WHtR 0.53 0.07 0.62 0.07 < 0.001
WBC (10^3/μL) 6.58 1.78 6.38 1.67 < 0.001
RBC (10^6/μL) 5.19 0.56 4.78 0.50 < 0.001
HGB (g/dL) 15.66 1.58 13.88 1.47 < 0.001
HCT (%) 44.39 3.82 39.99 3.74 < 0.001
MCV (fL) 86.17 7.49 84.18 7.61 < 0.001
MCH (pg) 30.44 3.14 29.28 3.16 < 0.001
MCHC (10^3/μL) 35.31 1.19 34.74 1.21 < 0.001
PLT (%) 247.71 60.71 296.38 72.93 < 0.001
Glucose (mg/dL) 90.19 24.25 94.56 32.98 < 0.001
BUN (mg/dL) 13.74 3.94 12.29 3.85 < 0.001
Cr (mg/dL) 1.06 0.18 0.92 0.18 < 0.001
TG (mg/dL) 135.98 90.80 128.50 74.82 < 0.001
Cholesterol (mg/dL) 178.82 37.90 190.39 39.44 < 0.001
SGOT (U/L) 23.84 8.41 21.56 8.91 < 0.001
SGPT (U/L) 26.09 16.52 21.29 12.02 < 0.001
ALP (U/L) 211.06 65.62 208.30 75.65 0.052
HDL (mg/dL) 47.26 14.42 54.20 16.42 < 0.001
LDL (mg/dL) 104.44 31.44 110.57 33.43 < 0.001
GGT (U/L) 25.82 22.56 20.42 20.07 < 0.001
DBP Diastolic blood pressure, SBP Systolic blood pressure, BMI Body mass
index, ABSI A body shape index, BAI Abdominal volume index, AVI Body
adiposity index, WHR Waist to hip ratio, WHtR Waist to height ratio, WBC White
blood cell, RBC Red blood cell, HGB Hemoglobin, HCT Hematocrit, MCV Mean
cell volume, MCH Mean corpuscular hemoglobin, MCHC Mean corpuscular
hemoglobin concentration, PLT Platelet, BUN Blood urea Nitrogen, Cr
Creatinine, TG Triglyceride, SGOT Serum glutamic oxaloacetic transaminase,
SGPT Serum glutamic pyruvic transaminase, ALP Alkaline phosphatase, HDL
High-density lipoprotein, LDL Low-density lipoprotein, GGT Gamma
glutamine transferase
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between men and women in the number of resting heart
rate and its high rate in women is something that has
been mentioned in previous studies [27, 28]. However,
this increased heart rate at rest in women does not mean
a higher risk of heart disease because the results of pre-
vious studies show that the power of the relationship be-
tween resting heart rate and all-cause mortality in
women is weaker than men [29].
As previous studies had shown, both systolic and dia-
stolic blood pressures were significantly related to rest-
ing heart rate in a positive way. There are some
investigations that demonstrated that the relationship
between RHR and SBP is stronger than DBP, such as
some studies in Finland, Norway, Belgium, and the USA
[12, 30]. We demonstrated that this relationship is stron-
ger in men than women like the results of Green et al.
and Cirillo et al. [31, 32]. Based on our knowledge, the
interaction between aging and RHR on blood pressure
still remains unexplained. The present study strongly in-
dicated that gender had a significant effect on the rela-
tionship between aging and increased RHR. Figure 2
shows a significant positive rate-response relationship
among SBP and RHR and inverse rate-response relation-
ship with DBP above 80th quantile both in men and
women for the first time. To shed new light on the
mechanism of this relationship, previous data suggested
that an increase in catecholamine concentration and
sympathetic nervous system over-activity could be major
mechanisms of this correlation [33, 34].
The Results of the present study confirm and extend the
finding of the Korea National Health and Nutrition Exam-
ination Survey (KNHANES) and the Third National
Health and Nutrition Survey (NHANES III) [16, 35]. We
observed a significant association between waist circum-
ference and RHR. Previous 20 years of longitudinal studies
and HARVEST study demonstrated that RHR is an im-
portant predictor of overweight and obesity, and each 10
bpm increase in RHR, increases the risk of obesity by 30%
[25, 36]. Our findings confirmed that central obesity con-
stantly linked with higher RHR, which may be due to
autonomic imbalance and adrenergic hyperactivity [33].
Also, the findings of this study, similar to Piwońska
et al. and Cooney et al. studies, demonstrated that there
is a positive association between BMI and RHR in the
general population [8, 30]. Furthermore, numerous stud-
ies have reported BMI and its positive relationship with
all causes of mortality and coronary artery disease, espe-
cially in patients with higher RHR [37–39].
A study in Japan on 3872 individuals demonstrated
that resting heart rate is a predictor of the metabolic
syndrome in the middle aged Japanese population [40].
We have provided further evidence that this relation is
in both sexes. The suggested mechanism explains the
pathway that starts by alteration in fat accumulation
neuronal signals from the liver and visceral fat to the
brain, this leads to modulate autonomic tone [41, 42].
Based on our observations, we conclude that: The effect
of resting heart rate as a potential predictor of metabolic
syndrome is biologically plausible.
Previous findings seem to demonstrated that there is a
significant relationship between HR and hsCRP as an in-
dicator of inflammation [43]. One of the explanations is
a genetic predisposition that leads to the sympathetic
nervous system (SNS) dysfunction which damages the
blood vessel wall. This pathway starts neurohormonal
inflammatory cascade and releases some cytokines such
Fig. 1 The frequency of use of different drugs in Fasa PERSIAN (Prospective Epidemiological Research Study in IrAN) cohort population (n = 9975)
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as TNF-α and IL-6, predominantly [44]. This pathway
induced a chronic systemic inflammatory and oxidative
stress state which lead to arterial stiffness and generation
of the atherosclerotic plaque [45, 46].
Compared to women, men had a higher level of trigly-
ceride but this superiority has no clinical importance.
On the other hand, Cholesterol, HDL, and LDL are sig-
nificantly higher in women. Findings reveal that there is
a weak relationship between triglyceride and RHR in
both sexes. Our findings are in agreement with the re-
sults of SUN Ji Chao in china [47]. Few studies also have
reported that significantly higher cholesterol and LDL
levels correlate with higher levels of RHR in both gen-
ders. In contrast to these studies, our results seem to
show no significant relationship between cholesterol and
RHR [48]. Suggested theories propose that a higher con-
centration of TG is due to catecholamine action and
leads to lipid metabolism alteration. This pathway cata-
lyzes HDL synthesis and decreases the concentration of
the LDL by α1 stimulation [48].
To the best of our knowledge, no previous study re-
ported the relationship between RHR and Hb. In
Fig. 2 Multivariate Scasde quantile regression between resting heart rate and suspected determinants in Fasa PERSIAN (Prospective
Epidemiological Research Study in IrAN) cohort
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particular, we found a positive weak association between
Hb and RHR. This relation has no definite and certain
reason or explanation. It is possible that people with
lower Hb, have a higher heart rate due to inadequate
oxygen supply respectively. Then, our findings seem to
show anemia may be considered as a minor cardiometa-
bolic risk factor.
Our findings showed that there is a clear relationship
between higher RHR and more blood glucose levels. Our
result is in agreement with previous data which have
been showing that increased risk of type 2 diabetes asso-
ciated with increased heart rate [10, 11, 35, 37]. Simi-
larly, Andrew Grandinetti et al. demonstrated that in the
general population, a significant increase in insulin
resistance titers observed in men and women with
higher HR [39]. The same results were driven from ana-
lysis of the Chicago Heart Association Detection Project
in Industry Study and Atherosclerosis Risk in the Com-
munities (ARIC) [1, 38, 49]. Some other theories have
been suggested about this matter, one is genetic factors
that determine cardiovascular fitness and also energy ex-
penditure [50–52]. Another theory explains that in-
creased activity of sympathetic nervous system tone can
lead to an increase in HR and alter the regulation of the
parasympathetic on the heart. Also, SNS overactivity
stimulates hyperinsulinemia in the accompaniment of
insulin resistance [53, 54]. Moreover, data reveals that
patients with diabetes have increased sympathetic and
Table 2 Results of SCAD linear regression to modeling resting heart rate in Fasa PERSIAN (Prospective Epidemiological Research
Study in IrAN) cohort
Variable Model 1a Variable Model 2b
β Standard β SE p- Value β Standard β SE p- Value
Sex (male is ref) 4.88 0.21 0.33 <0.001 Sex (male is ref) 4.62 0.22 0.211 <0.001
SBP 0.08 0.13 .006 <0.001 SBP 0.11 0.19 0.006 0.032
HDL.C 0.06 0.10 0.026 0.137 Beta1.blockers −2.35 −0.07 0.021 0.006
WBC 0.34 0.17 .32 .288 Age −0.05 − 0.05 − 0.03 0.012
GLUC 0.04 0.11 0.004 <0.001 BMI 0.08 0.04 0.07 0.003
Beta1.blockers 1.12 −0.06 0.002 <0.001 Opium −1.89 −0.04 0.28 <0.001
TG 0.01 0.06 0.001 <0.001 Levothyroxine −1.41 −0.02 0.42 <0.001
SGPT 0.006 0.009 0.007 0.39 Alpha. blockers 5.2 0.02 1.27 <0.001
DBP 0.171 0.193 0.009 .009 TCA 2.13 0.02 1.02 <0.001
Age −.018 −.016 .011 .111 Metformin 1.20 0.02 0.13 0.001
SGOT −.027 − 024 .12 .028 WC 0.39 0.003 0.043 0.008
BUN −0.21 −0.08 .027 <0.001 SSRI −1.00 − 0.01 − 0.91 <0.001
WC 0.12 0.05f 0.008 <0.001 WHR 2.29 0.01 0.031 <0.001
Opium −1.69 −0.13 0.004 <0.001 Antihistamine 1.55 0.01 0.178 0.003
TCA 1.94 0.02 1.12 <0.001 Beta2.agonist 2.2 0.01 0.98 .002
Alpha. blockers 4.87 0.02 1.32 <0.001 Diuretics 0.64 0.01 0.24 0.001
HGB 0.09 0.01 0.02 <0.001
Levothyroxine −0.93 −0.81 − 0.71 0.471
Metformin −11.78 −10.36 −3.41 0.291
SSRI −1.15 −0.01 −.98 0.003
Diuretics 0.87 0.005 0.73 0.004
LDL −0.01 −0.003 −0.02 0.006
Beta2.agonist 0.88 0.002 0.56 0.042
Antihistamine 1.46 3.11 0.74 0.639
ABSI −28.04 −0.001 −19.1 0.132
DBP Diastolic blood pressure, SBP Systolic blood pressure, BMI Body mass index, ABSI A body shape index, WHR Waist to hip ratio, WBC White blood cell, RBC Red
blood cell, HGB Hemoglobin, HCT Hematocrit, MCV Mean cell volume, MCH Mean corpuscular hemoglobin, MCHC Mean corpuscular hemoglobin concentration,
PLT Platelet, BUN Blood urea Nitrogen, Cr Creatinine, TG Triglyceride, SGOT Serum glutamic oxaloacetic transaminase, SGPT Serum glutamic pyruvic transaminase,
ALP Alkaline phosphatase, HDL High-density lipoprotein, LDL Low-density lipoprotein, GGT Gamma glutamine transferase
a Model 1, HR considered as dependent variable, and all of the other 41 factors (aforementioned in Table 1 and drugs) were considered as independent variables.
The proposed model represents 25 variables as effective factors on resting heart rate
b Only comprised age, sex, BMI, waist circumference, WHR, SBP, and drugs because the excluded variables show a bidirectional confounding relationship with RHR
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decreased parasympathetic activity respectively [55]. Sev-
eral studies have shown that a decrease in HR, even to a
small extent, can consequently have significant public
health benefits [56].
Strengths and limitations
One of the most important strengths of this study is the
large multiple biological and chemical variables that
have been evaluated concerning RHR, which able us to
take into account the potential confounding effect of
many variables. To the best of our knowledge, this is the
first study that assesses the relationship between a large
panel of cardiovascular risk factors and biochemical
data, and RHR.
Other strengths of this study are its type and large
sample size. This is a cohort study with about 10,000
participants that leads to more generalizability of the re-
sults. Also, the two-modeling analysis confirms the
consistency and importance of findings.
Some limitations of the present study are 1. The cross-
sectional nature of the study did not allow us to draw
causal conclusions due to the lack of follow-up data. 2.
We used the average of only two readings of resting
heart rate, taken only a few minutes apart, to represent
the resting heart rate for each participant. 3. the interfer-
ing effect of white coat syndrome and in-office stress
that might influence on blood pressure and heart rate, 4.
lack of measurement of heart rate variability to improve
the consistency of the findings and 5. the past medical
and medication history of the participants did not be
considered into the analysis.
Conclusion
This study revealed that female gender, lower
hemoglobin, obesity, and more BMI, more blood glucose
levels, more LDL, and more systolic blood pressure are
associated with more RHR. However, the investigation
into this area is in progress and seems more prospective
researches, especially with long periods of follow-ups
and multinational sources, are needed.
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